Novartis Culls Fevipiprant After LackLUSTER Data

Asthma Pill Fails Second Set Of Studies

 
• By Kevin Grogan
  
Tumbling blocks
Fevipiprant Fails To Stand Up In Asthma Studies • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Respiratory

More from Therapy Areas